Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Marta Martinez-Vicente
Based on 8 articles published since 2009
(Why 8 articles?)
||||
Expertise Level
The expertise of Marta Martinez-Vicente ranks in the
  • Top 1.7%
  • ... of 69,146 published authors worldwide on Parkinson Disease
  • ... from 2009 through 2019
  • ... based on contributions to 8 articles on the topic.
Graphical view (beta)
Aliases Martínez-Vicente, Marta   ·   Martinez-Vicente, Marta
Work Locations
Details
Most likely:    Instituto de Salud Carlos III      
2019
  • Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 08035, Barcelona, Spain. · Telethon Institute of Genetics and Medicine (TIGEM), 80078, Naples, Italy. · Department of Neurology, Tohoku University School of Medicine, Miyagi, 980-8574, Japan. · Department of Neurochemistry and Neuropharmacology, IIBB-CSIC, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)-Center for Networked Biomedical Research on Mental Health (CIBERSAM), 08036, Barcelona, Spain. · Neurological Tissue Bank, Biobanc Hospital Clínic-IDIBAPS, 08036, Barcelona, Spain. · Institute of Neurology, Medical University of Vienna, 1090, Vienna, Austria. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 08035, Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, 08193, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies (ICREA), 08010, Barcelona, Spain. · Pubmed 30846695
2014
  • Neurodegenerative Diseases Research Group; Vall d'Hebron Research Institute-CIBERNED; Barcelona, Spain. · Merck Serono S.A.; Geneva Research Center; Geneva, Switzerland. · Neurodegenerative Diseases Research Group; Vall d'Hebron Research Institute-CIBERNED; Barcelona, Spain; Department of Biochemistry and Molecular Biology; Autonomous University of Barcelona; Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA); Barcelona, Spain. · Pubmed 24686337
2013
  • Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-CIBERNED, Barcelona, Spain. · Pubmed 23499831
2017
  • UMR 5293, Institut des Maladies Neurodégénératives, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5293, Institut des Maladies Neurodégénératives, 33076 Bordeaux, France. · Vall d'Hebron Research Institute, CIBERNED and Catalan Institution for Research and Advanced Studies (ICREA), Autonomous University of Barcelona (UAB), Barcelona, Spain. · UMR 5297, Interdisciplinary Institute of Neurosciences, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5297, Interdisciplinary Institute of Neurosciences, 33076 Bordeaux, France. · Neurodegenerative Disease Department, Merck Serono Institute, Geneva, Switzerland. · Pubmed 28520872
Probable:    Vall d'Hebron Research Institut de Recerca      
2019
  • Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 08035, Barcelona, Spain. · Telethon Institute of Genetics and Medicine (TIGEM), 80078, Naples, Italy. · Department of Neurology, Tohoku University School of Medicine, Miyagi, 980-8574, Japan. · Department of Neurochemistry and Neuropharmacology, IIBB-CSIC, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)-Center for Networked Biomedical Research on Mental Health (CIBERSAM), 08036, Barcelona, Spain. · Neurological Tissue Bank, Biobanc Hospital Clínic-IDIBAPS, 08036, Barcelona, Spain. · Institute of Neurology, Medical University of Vienna, 1090, Vienna, Austria. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 08035, Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, 08193, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies (ICREA), 08010, Barcelona, Spain. · Pubmed 30846695
2014
  • Neurodegenerative Diseases Research Group; Vall d'Hebron Research Institute-CIBERNED; Barcelona, Spain. · Merck Serono S.A.; Geneva Research Center; Geneva, Switzerland. · Neurodegenerative Diseases Research Group; Vall d'Hebron Research Institute-CIBERNED; Barcelona, Spain; Department of Biochemistry and Molecular Biology; Autonomous University of Barcelona; Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA); Barcelona, Spain. · Pubmed 24686337
2013
  • Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-CIBERNED, Barcelona, Spain. · Pubmed 23499831
2017
  • UMR 5293, Institut des Maladies Neurodégénératives, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5293, Institut des Maladies Neurodégénératives, 33076 Bordeaux, France. · Vall d'Hebron Research Institute, CIBERNED and Catalan Institution for Research and Advanced Studies (ICREA), Autonomous University of Barcelona (UAB), Barcelona, Spain. · UMR 5297, Interdisciplinary Institute of Neurosciences, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5297, Interdisciplinary Institute of Neurosciences, 33076 Bordeaux, France. · Neurodegenerative Disease Department, Merck Serono Institute, Geneva, Switzerland. · Pubmed 28520872
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Marta Martinez-Vicente in 2009-2019 about Parkinson Disease:

  • Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis. 2019
  • Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration. 2017
  • BAX channel activity mediates lysosomal disruption linked to Parkinson disease. 2014
  • Lysosomal impairment in Parkinson's disease. 2013
  • Alpha-synuclein and protein degradation pathways in Parkinson's disease: a pathological feed-back loop. 2013
  • Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. 2012
  • Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. 2012
  • Protein degradation, aggregation, and misfolding. 2010
Show List of Full Article Records
Google Searches

Learn more about Marta Martinez-Vicente using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Instituto de Salud Carlos III
Vall d'Hebron Research Institut de Recerca
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Instituto de Salud Carlos III
2019
  • Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 08035, Barcelona, Spain. · Telethon Institute of Genetics and Medicine (TIGEM), 80078, Naples, Italy. · Department of Neurology, Tohoku University School of Medicine, Miyagi, 980-8574, Japan. · Department of Neurochemistry and Neuropharmacology, IIBB-CSIC, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)-Center for Networked Biomedical Research on Mental Health (CIBERSAM), 08036, Barcelona, Spain. · Neurological Tissue Bank, Biobanc Hospital Clínic-IDIBAPS, 08036, Barcelona, Spain. · Institute of Neurology, Medical University of Vienna, 1090, Vienna, Austria. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 08035, Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, 08193, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies (ICREA), 08010, Barcelona, Spain. · Pubmed 30846695
2014
  • Neurodegenerative Diseases Research Group; Vall d'Hebron Research Institute-CIBERNED; Barcelona, Spain. · Merck Serono S.A.; Geneva Research Center; Geneva, Switzerland. · Neurodegenerative Diseases Research Group; Vall d'Hebron Research Institute-CIBERNED; Barcelona, Spain; Department of Biochemistry and Molecular Biology; Autonomous University of Barcelona; Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA); Barcelona, Spain. · Pubmed 24686337
2013
  • Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-CIBERNED, Barcelona, Spain. · Pubmed 23499831
2017
  • UMR 5293, Institut des Maladies Neurodégénératives, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5293, Institut des Maladies Neurodégénératives, 33076 Bordeaux, France. · Vall d'Hebron Research Institute, CIBERNED and Catalan Institution for Research and Advanced Studies (ICREA), Autonomous University of Barcelona (UAB), Barcelona, Spain. · UMR 5297, Interdisciplinary Institute of Neurosciences, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5297, Interdisciplinary Institute of Neurosciences, 33076 Bordeaux, France. · Neurodegenerative Disease Department, Merck Serono Institute, Geneva, Switzerland. · Pubmed 28520872
Vall d'Hebron Research Institut de Recerca
2019
  • Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 08035, Barcelona, Spain. · Telethon Institute of Genetics and Medicine (TIGEM), 80078, Naples, Italy. · Department of Neurology, Tohoku University School of Medicine, Miyagi, 980-8574, Japan. · Department of Neurochemistry and Neuropharmacology, IIBB-CSIC, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)-Center for Networked Biomedical Research on Mental Health (CIBERSAM), 08036, Barcelona, Spain. · Neurological Tissue Bank, Biobanc Hospital Clínic-IDIBAPS, 08036, Barcelona, Spain. · Institute of Neurology, Medical University of Vienna, 1090, Vienna, Austria. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 08035, Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, 08193, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies (ICREA), 08010, Barcelona, Spain. · Pubmed 30846695
2014
  • Neurodegenerative Diseases Research Group; Vall d'Hebron Research Institute-CIBERNED; Barcelona, Spain. · Merck Serono S.A.; Geneva Research Center; Geneva, Switzerland. · Neurodegenerative Diseases Research Group; Vall d'Hebron Research Institute-CIBERNED; Barcelona, Spain; Department of Biochemistry and Molecular Biology; Autonomous University of Barcelona; Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA); Barcelona, Spain. · Pubmed 24686337
2013
  • Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-CIBERNED, Barcelona, Spain. · Pubmed 23499831
2017
  • UMR 5293, Institut des Maladies Neurodégénératives, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5293, Institut des Maladies Neurodégénératives, 33076 Bordeaux, France. · Vall d'Hebron Research Institute, CIBERNED and Catalan Institution for Research and Advanced Studies (ICREA), Autonomous University of Barcelona (UAB), Barcelona, Spain. · UMR 5297, Interdisciplinary Institute of Neurosciences, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5297, Interdisciplinary Institute of Neurosciences, 33076 Bordeaux, France. · Neurodegenerative Disease Department, Merck Serono Institute, Geneva, Switzerland. · Pubmed 28520872
5 Other Locations Show
Yearly article counts 10100122010
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.